Prothena Corp. (PRTA) Tops Q2 EPS by $2.28, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Prothena Corp (PRTA) PT Lowered to $24 at RBC Capital
August 9, 2024 6:27 AM EDTRBC Capital analyst Kennen MacKay lowered the price target on Prothena Corp (NASDAQ: PRTA) to $24.00 (from $28.00) while maintaining a Sector Perform rating.
The analyst comments "Pipeline programs remain on track with multiple readouts expected in the next 12 months from '012, prasinezumab, and... More
